Business

Photo

Wall St. boosted by earnings, S&P posts best week in nearly two years

NEW YORK - U.S. stocks closed out their best week in nearly two years on Friday, helped by earnings from Microsoft and Procter & Gamble and as concerns eased over the possible spread of Ebola in the United States. | Video

Recent Business News

Ford's lower profit beats estimates; sales down on F-150 launch

DETROIT - Ford Motor Co on Friday reported a 34 percent drop in third-quarter profit, and revenue fell due to the cost of introducing the F-150 pickup truck. | Video

5:15pm EDT

U.S. House panel to meet with safety regulators about Takata air bags next week

WASHINGTON/DETROIT - The U.S. House committee looking into the defective air bags made by Japanese supplier Takata Corp will hold an initial briefing with U.S. safety regulators next week to learn the details of the regional recalls affecting 10 automakers, a committee aide said on Friday.

U.S., Japan, Politics 12:32pm EDT

Ex-Bank of New York Mellon employee pleads guilty to insider trading

NEW YORK - A former Bank of New York Mellon Corp employee on Friday pleaded guilty to insider trading based on tips from a former Merck & Co Inc employee about potential pharmaceutical mergers.

25 European banks set to fail health checks: sources

FRANKFURT - A group of 25 banks have failed European health checks, while up to 10 of those continue to have a capital shortfall, two people familiar with the matter said on Friday, providing a snapshot of the health of the region's lenders. | Video

3:27pm EDT

Deutsche Bank braces for $1.3 billion in U.S., UK Libor fines: sources

FRANKFURT - Deutsche Bank is bracing to pay almost 1 billion euros ($1.3 billion) for Libor-related fines as it nears a deal with U.S. and UK authorities to settle allegations it attempted to manipulate the benchmark interest rate, two sources familiar with the matter said on Friday.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Big Pharma’s race to develop an Ebola vaccine

the World Health Organization made real news this week as it announced large-scale clinical trials, due to start in January, 2015, in the rush to vaccinate against the further spread of Ebola in West Africa.